White Matter Hyperintensities on a Brain MRI: What the Bright Spots Mean and What Raises the Risk

A brain MRI report that mentions "white matter hyperintensities" can sound alarming. The phrase describes bright patches on the scan. They are very common with age, they usually cause no symptoms by themselves, and they are one of the most studied markers of small blood vessel disease in the brain.

What are white matter hyperintensities on a brain MRI?

White matter is the brain's wiring: the fibres that connect one region to another. On an MRI, some areas of white matter look brighter than their surroundings. That brightness is the "hyperintensity".

The research definition says white matter hyperintensities (WMH) are hyperintensities on T2-weighted MRI that sit in the white matter. The 2013 STRIVE consensus, written by an international working group, set common terms and reporting standards for these small vessel disease features. The word "presumed" in the full term, "white matter hyperintensity of presumed vascular origin", matters. The scan shows a bright patch. It does not show why the patch is there.

The US National Institutes of Health describes white matter lesions as areas that "appear bright white on MRI scans" and says they represent an increase in water content. Reports may also call them "white matter changes" or "small vessel disease changes". These are overlapping names for the same kind of finding.

How common are they?

Common enough that finding some is not unusual. In the Rotterdam Scan Study, researchers scanned 1,077 people aged 60 to 90 who were randomly sampled from the general population. The proportion with white matter lesions increased with age, similarly for men and women.

A 2019 systematic review of large MRI studies also calls WMH "a common finding in elderly people". So a few small spots in an older adult is an ordinary result. The useful questions are how many there are, where they sit, and what else is going on.

How do radiologists grade them?

Many reports use the Fazekas scale, published in 1987. It rates the white matter right next to the fluid-filled ventricles (periventricular) and the deeper white matter separately, each from 0 to 3.

Grade 1 is the mildest finding. Grade 3 is the most extensive. This is a visual rating done by a person looking at the images.

What do they mean for stroke, dementia and death?

The best single summary is the 2010 Debette and Markus systematic review and meta-analysis in the BMJ. It reviewed 46 longitudinal studies and pooled 22 of them. The pooled hazard ratios compare people with WMH to people without:

The authors concluded that "white matter hyperintensities predict an increased risk of stroke, dementia, and death". They also reported that an association with faster decline in global cognitive performance, executive function, and processing speed was suggested.

Read these numbers as group averages. A hazard ratio of 3.3 does not mean 3.3 out of 10 people will have a stroke. It means that, across those studies, stroke happened at a higher rate in people with WMH. It does not tell you what will happen to one person, and it does not show that the spots themselves are the cause. They are better read as a marker that the brain's small vessels have had a hard life.

What raises the risk, and can blood pressure control slow it?

Age is the clearest link, as the Rotterdam data above show. High blood pressure is the other one the NIH names: it says white matter changes "are associated with high blood pressure". That is an association, and it is the reason these findings often lead to a blood pressure conversation.

The strongest test so far is the SPRINT MIND MRI substudy, published in JAMA in 2019. It followed 449 adults who returned for a follow-up brain MRI, out of 670 scanned at baseline. Their mean age at the start was 67.3 years. They had high blood pressure and no diabetes or prior stroke. They were randomly assigned to an intensive systolic target (below 120 mm Hg) or a standard target (below 140 mm Hg). The follow-up scan came at a median of 3.97 years after randomization.

• Intensive group: white matter lesion volume rose from 4.57 to 5.49 cm³ (a rise of 0.92 cm³).
• Standard group: it rose from 4.40 to 5.85 cm³ (a rise of 1.45 cm³).
• Difference between groups: -0.54 cm³ (95% CI -0.87 to -0.20).

So lowering blood pressure more was associated with a smaller increase, but the lesions still grew in both groups. The authors called the differences small. Total brain volume also fell slightly more in the intensive group (a between-group difference of 3.7 cm³), which the NIH described as very small and of unclear clinical significance. The result applies to people like those enrolled, and it does not show that lesions shrink once they exist. If you are not sure how to read your own readings, our guide to blood pressure numbers and home monitoring is a good place to start.

What should you do if your report mentions them?

1. Ask for the grade and location. "A few punctate spots" and "large confluent areas" are different findings.
2. Check your blood pressure over several days, not once in a clinic.
3. Review the other vascular factors with your doctor, such as blood sugar and cholesterol.
4. Note any symptoms. Memory change, slowed thinking, balance problems or a past stroke change how the finding is read. Our guide to what is normal and what deserves attention in brain aging covers this.
5. Do not set your own rescan schedule. Whether and when to repeat imaging depends on your history.

Where do white matter hyperintensities fit in a screening visit?

WMH are found on brain MRI. They are a finding in brain tissue. Brain MR Angiography is a different test: it produces images of the brain's blood vessels, not of the white matter.

If your question is about the brain's vessels, our Brain MR Angiography is $699 (/book/70). The Advanced Package with Brain MRA is $3,799 (/book/8). For broader imaging, our Full-Body Scans line is built around full-body MRI: Light is $1,399 (/book/5), Complete is $1,699 (/book/6), and Plus is $3,099 (/book/7). You can compare them on our health screening page, and check each package's inclusion list for exactly what it covers before you book.

No scan can say which bright spots will matter for you, and whole-body imaging has its own trade-offs, which we cover in what the evidence shows on whole-body MRI. Bring any result to a doctor who can read it alongside your blood pressure, history and symptoms.

Sources

• PubMed (BMJ 2010) — Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis (accessed 2026-10-29)
• PubMed (JAMA 2019) — Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions (accessed 2026-10-29)
• NHLBI, NIH — Intensive blood pressure control may slow age-related brain damage (accessed 2026-10-29)
• PubMed (Lancet Neurology 2013) — Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (accessed 2026-10-29)
• PubMed (J Neurol Neurosurg Psychiatry 2001) — Prevalence of cerebral white matter lesions in elderly people: the Rotterdam Scan Study (accessed 2026-10-29)
• Frontiers in Neurology 2019 — Frey BM et al., Characterization of White Matter Hyperintensities in Large-Scale MRI-Studies (accessed 2026-10-29)
• Radiopaedia — Fazekas scale for white matter lesions, citing Fazekas et al., AJR 1987 (accessed 2026-10-29)
• AJR — Fazekas F et al., MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging, 1987 (accessed 2026-10-29)